“The Role of Intralesional Glucantime in Treating Cutaneous Leishmaniasis Lesions Complicated by Secondary Bacterial Infections: Research Article”. 2025. Pak-Euro Journal of Medical and Life Sciences 8 (1): 219-26. https://doi.org/10.31580/pjmls.v8i1.3238.